4basebio PLC has been granted Good Manufacturing Practice (GMP) certification by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). This licence authorises the supply of GMP-grade synthetic DNA to support clinical programs in cell and gene therapy and vaccine development. The Cambridge-based company’s proprietary synthetic DNA platform delivers flexible, high-performance DNA tailored to diverse applications. Source: Pharma Times 2/4/2025